Mefeclorazine
Neuroleptic
From Wikipedia, the free encyclopedia
Mefeclorazine (INN) is a neuroleptic (antipsychotic) of the phenethylamine and arylpiperazine groups.[1][2][3]
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H25ClN2O2 |
| Molar mass | 360.88 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Part of mefeclorazine's chemical structure is based on 3,4-dimethoxyphenethylamine (DMPEA or homoveratrylamine), which has structural similarity to the neurotransmitter dopamine.[1] Mefeclorazine was invented by Jack Mills of Eli Lilly in 1958.[4] Although it is not known to have ever been used clinically,[1] it is based on a chemically rational synthetic design.
The ortho-chlorophenylpiperazine (oCPP) moiety forms part of the molecular structure.[1] This precursor finds dual use in the synthesis of the arylpiperazines enpiprazole and KMUP-1.[citation needed]